SMTL ID : 7czd.2 (1 other biounit)

Crystal structure of PD-L1 in complex with a VHH

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

hetero-1-1-mer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain B: A.35, Y.101, G.102 1 PLIP interactions: 1 interactions with chain B Water bridges: B:G.102 EDO.2: 4 residues within 4Å: Chain B: L.70, L.71, K.72, D.73 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:L.70, B:K.72, B:K.72, B:D.73, B:D.73 Water bridges: B:R.69 EDO.3: 2 residues within 4Å: Chain B: K.107, R.108 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:R.108, B:R.108, B:R.108

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.4: 2 residues within 4Å: Chain B: P.26, E.28 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhai, T. et al., Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. J Immunother Cancer (2021)

Release Date

2021-07-14

Peptides

anti-PD-L1 VHH: A
Programmed cell death 1 ligand 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

anti-PD-L1 VHH

Programmed cell death 1 ligand 1

Related Entries With Identical Sequence